Xu Huaqiang is the founder of Cascade. Cascade has raised $66M in total funding. Latest round: Series D. Based in Shanghai, China.
Xu Huaqiang leads the R&D team at Cascade Pharmaceuticals, focusing on structural biology and nuclear receptor drug design. His team is recognized for its ability to translate proprietary intellectual property into differentiated clinical pipelines for metabolic and inflammatory diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library